Home
Christopher John Kenney, Chief Medical Officer: Xenon Pharmaceuticals XENE Sell · Filed 03/13
Trade details
- Type
- Insider sale
- Amount
- $77,874.3
- Shares · price
- 1,410 sh · $55.23 a share
- Held after
- 7,069 sh
- Trade date
- 26/03/13
- Filed
- 26/03/13
- Days to filing
- 0 days
Sold 16.6% of holdings
- Share of holding sold
- 16.6%
Xenon Pharmaceuticals trades, last 26 weeks
What else happened in Xenon Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 02/11~04/12Christopher John Kenney's recent trades
- Christopher John Kenney
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 planXenon Pharmaceuticals
XENE
$437.7K
7,068 sh
$437.7K
Filed 08/28
Traded 08/28
- Christopher John Kenney
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 planXenon Pharmaceuticals
XENE
$77.9K
1,410 sh
$77.9K
Filed 03/13
Traded 03/13
- Christopher John Kenney
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 planXenon Pharmaceuticals
XENE
$166.6K
2,771 sh
$166.6K
Filed 03/11
Traded 03/10
- Christopher John Kenney
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 planXenon Pharmaceuticals
XENE
$166.6K
2,771 sh
$166.6K
Filed 03/10
Traded 03/10
- Christopher John Kenney
SellXenon Pharmaceuticals
SellXenon Pharmaceuticals
XENE
$24.5K
700 sh
$24.5K
Filed 23/03/24
Traded 23/03/24